Probiotic effects of Clostridium cellabutyricum YQ-FP-027T on DSS-induced colitis mice via modulating gut microbiota and preventing inflammation
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114642 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yuan-Jie Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Chongqing Medical University, No. 61 Daxuecheng Middle Road, Shapingba District, Chongqing 401334, PR China. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Colitis, Clostridium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Chongqing Municipal Education Commission, Chongqing Municipal Science and Technology Bureau, National Natural Science Foundation of China.
Abstract (Originalsprache)
Butyrate-producing Clostridium spp. play fundamental roles in maintaining gut microbiota homeostasis by producing short-chain fatty acids. However, exploration of the strain resources and their probiotic effects remains limited. In previous work, a novel species of butyrate-producing Clostridium, Clostridium cellabutyricum YQ-FP-027T, was isolated from the pit mud of Chinese Baijiu brewing, which possesses antibacterial activities by modulating gut microbiota. The present study investigated the probiotic effects of YQ-FP-027T on mice with dextran sulfate sodium (DSS)-induced colitis and the underlying mechanism. The results showed that the mice treated with YQ-FP-027T exhibited lower disease activity index (DAI), recovered weight loss, and reduced colon shortening. Regarding gut microbial composition, these mice showed increased Shannon and Species richness observed (Sobs) indexes and a rising abundance of beneficial bacteria such as Akkermansia and Alistipes. Additionally, the expression levels of inflammatory factors Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α) were suppressed, while those of anti-inflammatory factor Interleukin-10 (IL-10) and the cathelicidin-related antimicrobial peptide (CRAMP) were enhanced under YQ-FP-027T treatment. These results suggest that YQ-FP-027T holds potential as a promising probiotic against DSS-induced colitis via optimizing gut microbial community structure and modulating gut immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Public Health, Chongqing Medical University, No. 61 Daxuecheng Middle Road, Shapingba District, Chongqing 401334, PR China.
- College of Public Health, Chongqing Medical University, No. 61 Daxuecheng Middle Road, Shapingba District, Chongqing 401334, PR China. Electronic address: yinqibio@cqmu.edu.cn.
Förderung
- Chongqing Municipal Education Commission
- Chongqing Municipal Science and Technology Bureau
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y. J., Wang, M. L., Li, Y., Lu, X. L., Liu, X. R., Hu, D. X., Chen, A., & Yin, Q. (2025). Probiotic effects of Clostridium cellabutyricum YQ-FP-027T on DSS-induced colitis mice via modulating gut microbiota and preventing inflammation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114642
Vancouver
Zhang YJ, Wang ML, Li Y, Lu XL, Liu XR, Hu DX, et al. Probiotic effects of Clostridium cellabutyricum YQ-FP-027T on DSS-induced colitis mice via modulating gut microbiota and preventing inflammation. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114642
BibTeX
@article{Zhang2025,
author = {Zhang, Yuan-Jie and Wang, Meng-Lin and Li, Yingli and Lu, Xiao-Ling and Liu, Xiang-Ru and Hu, Dai-Xin and Chen, Anyi and Yin, Qi},
title = {Probiotic effects of Clostridium cellabutyricum YQ-FP-027T on DSS-induced colitis mice via modulating gut microbiota and preventing inflammation},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114642}
}
EUVIMED